|
|
|
Insider
Information: |
Thompson Virgil |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
1,023,415 |
|
Indirect Shares
|
123,849 |
|
|
Direct
Value |
$3,756 |
|
|
Indirect Value
|
$27,866 |
|
|
Total
Shares |
1,147,264 |
|
|
Total
Value |
$31,622 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2013-12-04 |
0 |
2003-06-30 |
0 |
Premium* |
|
Aradigm Corp |
ARDM |
Director |
2013-12-13 |
1,006,722 |
2009-05-15 |
0 |
Premium* |
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2023-06-27 |
16,693 |
2023-06-27 |
123,849 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCSA |
Processa Pharmaceuticals,... |
|
|
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
23,636 |
123,849 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
I/I |
18,208 |
100,213 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,169 |
16,693 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,393 |
16,693 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2021-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,169 |
12,300 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,861 |
|
% |
|
PCSA |
Processa Pharmaceuticals,... |
Director |
|
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
80,836 |
|
% |
|
ARDM |
Aradigm Corp |
Director |
|
2013-12-13 |
4 |
OE |
$0.16 |
$1,600 |
D/D |
10,000 |
1,006,722 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2013-12-13 |
4 |
S |
$0.17 |
$568 |
D/D |
(3,340) |
996,722 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2013-12-04 |
4 |
S |
$0.02 |
$2,455 |
D/D |
(106,751) |
0 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2013-05-22 |
4 |
A |
$0.15 |
$50,000 |
D/D |
333,333 |
1,000,062 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2012-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
166,667 |
666,729 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2011-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
131,579 |
500,062 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2011-05-26 |
4 |
A |
$7.78 |
$41,164 |
D/D |
5,291 |
60,193 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2010-09-02 |
4 |
OE |
$11.81 |
$88,598 |
D/D |
7,500 |
54,902 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2010-06-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,514 |
47,402 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2010-06-08 |
4 |
A |
$11.38 |
$39,989 |
D/D |
3,514 |
47,402 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2010-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
208,333 |
368,483 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2009-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
156,250 |
160,150 |
0 |
- |
|
ARDM |
Aradigm Corp |
Director |
|
2009-05-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
156,250 |
160,150 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2009-05-05 |
4 |
A |
$5.37 |
$39,996 |
D/D |
7,448 |
43,888 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2008-06-03 |
4 |
OE |
$7.88 |
$59,100 |
D/D |
7,500 |
43,940 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2008-05-13 |
4 |
A |
$24.66 |
$39,999 |
D/D |
1,622 |
36,440 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2007-05-15 |
4 |
A |
$12.77 |
$41,847 |
D/D |
3,277 |
34,818 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
Director |
|
2007-03-30 |
4 |
A |
$12.02 |
$3,738 |
D/D |
311 |
31,541 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|